Skip to content

Gradual vs. Abrupt Cessation Treatment for Smoking

Gradual vs. Abrupt Cessation Treatment for Smoking

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00297492
Enrollment
750
Registered
2006-02-28
Start date
2006-01-31
Completion date
2008-02-29
Last updated
2013-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

Smoking Cessation, Tobacco

Brief summary

This study tests whether stopping smoking by gradually cutting down first is more or less successful than stopping abruptly. We hypothesize that stopping by gradually cutting down first will produce more abstinence than stopping abruptly.

Detailed description

For cigarette smokers who intend to stop smoking, most treatment guidelines recommend abrupt cessation. There is evidence from some small studies that gradually reducing the number of cigarettes per day smoked may increase success in quitting. In this study, we will randomize smokers who want to quit smoking in the next 30 days to one of three groups: gradual reduction, abrupt cessation, and minimal intervention.

Interventions

BEHAVIORALReduction Phone Counseling

Counseling of smokers to undergo gradual reduction in cigarettes per day prior to quit date. This includes 5 counseling calls: 3 calls focused on reduction prior to the quit date, 1 call two days prior to the quit date to discuss common strategies for preparing to quit, and 1 call two days after the quit date to discuss relapse prevention. Telephone counseling also discusses the proper use of nicotine lozenges during reduction and after the quit date.

BEHAVIORALAbrupt Phone Counseling

Counseling of smokers to set a quit date and not change cigarettes per day prior to quit date. This includes 5 counseling calls: 1 to set a quit date, 1 two days prior to the quit date to discuss common strategies for preparing to quit, and 3 after the quit date to discuss relapse prevention. Telephone counseling also discusses the proper use of nicotine lozenges after the quit date.

BEHAVIORALMinimal Abrupt Phone Counseling

Minimal counseling to mimic intervention at a primary care office. This includes 2 counseling calls: 1 to set a quit date and 1 two days after the quit date to discuss relapse prevention. Telephone counseling also discusses the proper use of nicotine lozenges after the quit date.

DRUGPre-Quit Nicotine Lozenges

2 mg lozenges for participants usually smoke their first cigarette more than 30 minutes after awaking. 4 mg lozenge for participants who usually smoke their first cigarette less than 30 minutes after awaking. Replace each forgone cigarette during reduction with one lozenge. Use additional lozenges to combat cravings to smoke.

DRUGPost-Quit Nicotine Lozenges

2 mg lozenges for participants usually smoke their first cigarette more than 30 minutes after awaking. 4 mg lozenge for participants who usually smoke their first cigarette less than 30 minutes after awaking. Replace each forgone cigarette while abstinent with one lozenge. Use additional lozenges to combat cravings to smoke.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Vermont
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Interested in quitting gradually * At least 18 years old * Daily cigarette smoker * Smoke at least 15 cigarettes per day (CPD) * No change greater than 20% in CPD in the last month * Interested in quitting in next 30 days * Must agree to not use non-cigarette tobacco during study * No use of smoking cessation medication in last month * Have phone with voice mail * Willing to use nicotine lozenge * No other person in household in study * Fluent/literate in English

Exclusion criteria

* Women who are pregnant or breastfeeding * Currently using medication for depression or asthma * Heart disease requiring medication * Heart attack in last month * Irregular heartbeat * High blood pressure not controlled by medication * Stomach ulcers * Diabetes

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Prolonged Abstinence Through 6 Months Verified by Carbon Monoxide Measurement6 monthsNumber of participants with self-reported prolonged abstinence from cigarette smoking through 6 months of follow-up, verified by a breath carbon monoxide reading of less than 10 parts per million

Countries

United States

Participant flow

Recruitment details

Participants were recruited using advertisements targeting smokers who wanted to quit smoking gradually. Advertisements were placed in newspapers in two cities in South Carolina and one city in New Mexico.

Pre-assignment details

Enrolled sample size of 750; 4 were excluded because found to be ineligible after enrollment.

Participants by arm

ArmCount
Gradual Reduction
Counseling of smokers to undergo gradual reduction in cigarettes per day prior to quit date
297
Abrupt Cessation
Counseling of smokers to set a quit date and not change cigarettes per day prior to quit date
299
Minimal Intervention
Minimal intervention to mimic intervention at a primary care office
150
Total746

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
6 Month Follow-upLost to Follow-up634927
Set Quit DateLost to Follow-up7135

Baseline characteristics

CharacteristicMinimal InterventionGradual ReductionTotalAbrupt Cessation
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
11 Participants24 Participants58 Participants23 Participants
Age, Categorical
Between 18 and 65 years
139 Participants273 Participants688 Participants276 Participants
Age Continuous47 years
STANDARD_DEVIATION 13
48 years
STANDARD_DEVIATION 13
48 years
STANDARD_DEVIATION 13
48 years
STANDARD_DEVIATION 12
Region of Enrollment
United States
150 participants297 participants746 participants299 participants
Sex: Female, Male
Female
80 Participants159 Participants404 Participants165 Participants
Sex: Female, Male
Male
70 Participants138 Participants342 Participants134 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
0 / 2970 / 2990 / 150
serious
Total, serious adverse events
0 / 2970 / 2990 / 150

Outcome results

Primary

Number of Participants With Prolonged Abstinence Through 6 Months Verified by Carbon Monoxide Measurement

Number of participants with self-reported prolonged abstinence from cigarette smoking through 6 months of follow-up, verified by a breath carbon monoxide reading of less than 10 parts per million

Time frame: 6 months

Population: This was an intent-to-treat analysis. Those who were lost to follow-up were assumed to not be abstinent from smoking at the time of the 6 month follow-up.

ArmMeasureValue (NUMBER)
Gradual ReductionNumber of Participants With Prolonged Abstinence Through 6 Months Verified by Carbon Monoxide Measurement12 participants
Abrupt CessationNumber of Participants With Prolonged Abstinence Through 6 Months Verified by Carbon Monoxide Measurement20 participants
Minimal InterventionNumber of Participants With Prolonged Abstinence Through 6 Months Verified by Carbon Monoxide Measurement7 participants
Comparison: Null hypothesis: prolonged abstinence from smoking is the same for the three groups at 6 month follow-up~Sample size was based on an assumption of 6 month abstinence of 25% in the gradual group, 15% in the abrupt group, and 10% in the minimal group. Sample sizes of 300, 300, and 150 for gradual, abrupt, and minimal provides 97% to detect a difference between the groups, with 2-sided alpha = 0.05.p-value: 0.3Chi-squared
95% CI: [0.28, 1.22]

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026